YJYindi Jiang

Yindi Jiang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yindi Jiang has a total of 26 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Enzymatic Basis of Stereochemical Control in Reserpine Biosynthesis

    by Jiaqing Cao, Jingxiao Zhong, Feng Li, Yindi Jiang

    Reserpine is a landmark natural product that has profoundly influenced our understanding of neurotransmitter biology and cardiovascular medicine. Its complex structure, featuring a unique C3 β-configuration and five consecutive chiral centers, has inspired generations of synthetic chemists to develop innovative strategies for its construction. However, the biosynthetic logic underlying nature's stereochemical control in the assembly of this intricate molecule has remained elusive. Here, we investigate the biosynthetic pathway of reserpine in Rauvolfia verticillata, revealing that α-configured strictosidine serves as the biosynthetic precursor. The crucial C3 β-configuration is established through a two-step enzymatic epimerization, orchestrated by a flavin-dependent oxidase and a NADPH-dependent reductase. The consecutive chiral centers are constructed through coordinated action of distinct enzyme families. Through the identification of eight biosynthetic enzymes, including those catalyzing late-stage methoxylation, we successfully reconstituted the biosynthesis of rauvomitorine G, which contains all the stereochemical features present in reserpine. This work unveils nature's elegant approach to stereoselective synthesis of complex alkaloids and provides valuable biocatalytic tools for molecular functionalization.


  • Collective Biosynthesis of Plant Spirooxindole Alkaloids through Enzyme Discovery and Engineering

    by Danni Chu, Hongkui Wang, Zhiwen Nie, Kang-Li Li, Jiaqing Cao, Meijing Yang, Qin Yin, Yang Gu, Yindi Jiang

    Collective synthesis is a well-established strategy to produce natural product collections from common intermediates. Extending this concept to enzymatic systems, collective biosynthesis offers a sustainable approach to diverse molecular collections but faces distinct challenges, including incomplete pathway knowledge and narrow substrate specificity of biosynthetic enzymes. Here, we overcome these limitations through enzyme discovery and protein engineering to achieve collective biosynthesis of spirooxindole alkaloids, an important class of natural products with diverse biological activities. We identified two key enzymes that catalyze enzymatic epimerization, working sequentially with a previously discovered cytochrome P450 enzyme to fully elucidate the biosynthetic pathway of pentacyclic spirooxindole alkaloids. Structure-guided engineering enhanced substrate recognition capability, enabling collective biosynthesis of 12 tetracyclic and pentacyclic spirooxindole natural products. We also generated new-to-nature fluorinated and deuterated derivatives through precursor-directed biosynthesis. This work provides crucial insights into plant spirooxindole alkaloid biosynthesis while establishing a powerful approach for sustainable production of complex natural products.


  • Open Access

    Collective biosynthesis of plant spirooxindole alkaloids through enzyme discovery and engineering

    by Danni Chu, Hongkui Wang, Zhiwen Nie, Kang-Li Li, Jiaqing Cao, Meijing Yang, Qin Yin, Yang Gu, Yindi Jiang

    Collective synthesis is a well-established strategy to produce natural product collections from common intermediates. Extending this concept to enzymatic systems, collective biosynthesis offers a sustainable approach to diverse molecular collections but faces distinct challenges, including incomplete pathway knowledge and narrow substrate specificity of biosynthetic enzymes. Here, we overcome these limitations through enzyme discovery and protein engineering to achieve collective biosynthesis of spirooxindole alkaloids, an important class of natural products with diverse biological activities. We identified two key enzymes that catalyze enzymatic epimerization, working sequentially with a previously discovered cytochrome P450 enzyme to fully elucidate the biosynthetic pathway of pentacyclic spirooxindole alkaloids. Structure-guided engineering expanded substrate scope, enabling collective biosynthesis of 12 tetracyclic and pentacyclic spirooxindole natural products. We also generated new-to-nature fluorinated and deuterated derivatives through precursor-directed biosynthesis. This work provides crucial insights into plant spirooxindole alkaloid biosynthesis while establishing a powerful approach for sustainable production of complex natural products.

  • Open Access

    Elucidation of the biosynthetic pathway of reserpine

    by Jiaqing Cao, Jingxiao Zhong, Feng Li, Yindi Jiang

    Reserpine is a landmark natural product that has profoundly influenced our understanding of neurotransmitter biology and cardiovascular medicine. Its complex structure, featuring a unique C3 β-configuration and five consecutive chiral centers, has inspired generations of synthetic chemists to develop innovative strategies for its construction. However, the biosynthetic logic underlying nature’s assembly of this intricate molecule has remained elusive. Here, we decipher the biosynthetic pathway of reserpine in Rauvolfia verticillata , revealing that α-configured strictosidine serves as the biosynthetic precursor. The crucial C3 β-configuration is established through a two-step enzymatic epimerization, orchestrated by a flavin-dependent oxidase and a NADPH-dependent reductase. The consecutive chiral centers are constructed through coordinated action of distinct enzyme families. Through the identification of eight biosynthetic enzymes, including those catalyzing late-stage methoxylation, we successfully reconstituted the biosynthesis of rauvomitorine G, a key intermediate in reserpine formation. This work unveils nature’s elegant approach to stereoselective synthesis of complex alkaloids and provides valuable biocatalytic tools for molecular functionalization.


  • Open Access

    The reactivity of an unusual amidase may explain colibactin’s DNA cross-linking activity

    by Yindi Jiang, Alessia Stornetta, Peter W. Villalta, Matthew R. Wilson, Paul D. Boudreau, Li Zha, Silvia Balbo, Emily P. Balskus

    Certain commensal and pathogenic bacteria produce colibactin, a small molecule genotoxin that causes interstrand cross-links in host cell DNA. Though colibactin has been found to alkylate DNA, the molecular basis for cross-link formation is unclear. Here, we report that the colibactin biosynthetic enzyme ClbL is an amide bond-forming enzyme that links aminoketone and β-keto thioester substrates in vitro and in vivo . The substrate specificity of ClbL strongly supports a role for this enzyme in terminating the colibactin NRPS-PKS assembly line. This transformation would incorporate two electrophilic cyclopropane warheads into the final natural product scaffold. Overall, this work provides a biosynthetic explanation for colibactin’s DNA crosslinking activity and paves the way for further study of its chemical structure.


  • Top Cited Papers

    The human gut bacterial genotoxin colibactin alkylates DNA

    by Matthew R. Wilson, Yindi Jiang, Peter W. Villalta, Alessia Stornetta, Paul D. Boudreau, Andrea Carrá, Caitlin A. Brennan, Eunyoung Chun, Lizzie Ngo, Leona D. Samson, et al.

    Bacterial warhead targets DNA: The bacterial toxin colibactin causes double-stranded DNA breaks and is associated with the occurrence of bacterially induced colorectal cancer in humans. However, isolation of colibactin is difficult, and its mode of action is poorly understood. Wilson et al. studied Escherichia coli that contain the biosynthetic gene island called pks , which is associated with colibactin production (see the Perspective by Bleich and Arthur). They identified the DNA adducts that resulted from incubating pks + E. coli in human cells. To overcome the lack of colibactin for direct analysis, mimics of the pks product were synthesized. From the resulting synthetic adenine-colibactin adducts, it became evident that alkylation via a cyclopropane “warhead” breaks the DNA strands. Similar DNA adducts were then identified in the gut epithelia of mice infected with pks + E. coli. Science , this issue p. eaar7785 ; see also p. 689